Literature DB >> 23385797

High glucose-induced downregulation of connexin 30.2 promotes retinal vascular lesions: implications for diabetic retinopathy.

Julia Manasson1, Thomas Tien, Colleen Moore, Nalin M Kumar, Sayon Roy.   

Abstract

PURPOSE: To investigate whether high glucose (HG) alters expression of connexin 30.2 (Cx30.2) and influences gap junction intercellular communication (GJIC) in retinal endothelial cells and promotes vascular lesions characteristic of diabetic retinopathy (DR).
METHODS: Western blot analysis and immunostaining were performed to determine Cx30.2 protein expression and localization in rat retinal endothelial cells (RRECs) grown in normal (N; 5 mM) or HG (30 mM) medium for 7 days. Concurrently, GJIC was assessed in cells grown in N or HG medium and in cells transfected with Cx30.2 siRNA. Similarly, retinal Cx30.2 expression was assessed in nondiabetic and diabetic rats. Additionally, the effect of reduced Cx30.2 on development of acellular capillaries (ACs) and pericyte loss (PL) was studied in retinas of Cx30.2 knockout mice.
RESULTS: Cx30.2 was identified in RRECs in vitro and in vascular cells of retinal capillaries. RRECs grown in HG exhibited significantly reduced Cx30.2 protein levels consistent with decreased Cx30.2 immunostaining compared with those grown in N medium. Cells grown in HG and cells transfected with Cx30.2 siRNA exhibited significantly diminished dye transfer compared with N or nontransfected cells. Importantly, Cx30.2 protein level and immunostaining were decreased in diabetic retinas compared with nondiabetic retinas. Retinal capillaries of Cx30.2 knockout mice exhibited increased numbers of ACs and PL compared with those of wild-type mice.
CONCLUSIONS: These results indicate that HG- or diabetes-induced downregulation of Cx30.2 expression and decrease in GJIC activity play a critical role in the development of retinal vascular lesions in early DR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23385797      PMCID: PMC3626527          DOI: 10.1167/iovs.12-10815

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

Review 1.  The gap junction communication channel.

Authors:  N M Kumar; N B Gilula
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

Review 2.  Functional redundancy and compensation among members of gap junction protein families?

Authors:  Peter Bedner; Christian Steinhäuser; Martin Theis
Journal:  Biochim Biophys Acta       Date:  2011-10-21

3.  Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability.

Authors:  Toshiyuki Oshitari; Peter Polewski; Manish Chadda; An-Fei Li; Tsuyoshi Sato; Sayon Roy
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

4.  Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis.

Authors:  Sarah F Giardina; Maya Mikami; Farida Goubaeva; Jay Yang
Journal:  Biochem Biophys Res Commun       Date:  2007-08-22       Impact factor: 3.575

5.  Distribution of connexin43 immunoreactivity in the retinas of different vertebrates.

Authors:  U Janssen-Bienhold; R Dermietzel; R Weiler
Journal:  J Comp Neurol       Date:  1998-07-06       Impact factor: 3.215

6.  Cx30.2 can form heteromeric gap junction channels with other cardiac connexins.

Authors:  Joanna Gemel; Xianming Lin; Raymond Collins; Richard D Veenstra; Eric C Beyer
Journal:  Biochem Biophys Res Commun       Date:  2008-02-20       Impact factor: 3.575

Review 7.  Gap junctions in the control of vascular function.

Authors:  Xavier F Figueroa; Brian R Duling
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

Review 8.  Current approaches and perspectives in the medical treatment of diabetic retinopathy.

Authors:  Massimo Porta; Attilio Allione
Journal:  Pharmacol Ther       Date:  2004-08       Impact factor: 12.310

9.  Effects of ageing and streptozotocin-induced diabetes on connexin43 and P2 purinoceptor expression in the rat corpora cavernosa and urinary bladder.

Authors:  Sylvia O Suadicani; Marcia Urban-Maldonado; Moses T Tar; Arnold Melman; David C Spray
Journal:  BJU Int       Date:  2009-01-14       Impact factor: 5.588

10.  High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells.

Authors:  An-Fei Li; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

View more
  6 in total

1.  Cx30.2 deletion causes imbalances in testicular Cx43, Cx46, and Cx50 and insulin receptors. Reciprocally, diabetes/obesity alters Cx30.2 in mouse testis.

Authors:  R-Marc Pelletier; Hamed Layeghkhavidaki; Nalin M Kumar; María Leiza Vitale
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-29       Impact factor: 3.619

Review 2.  Cell-cell communication in diabetic retinopathy.

Authors:  Sayon Roy; Dongjoon Kim; Remington Lim
Journal:  Vision Res       Date:  2017-06-28       Impact factor: 1.886

Review 3.  Connexin channel and its role in diabetic retinopathy.

Authors:  Sayon Roy; Jean X Jiang; An-Fei Li; Dongjoon Kim
Journal:  Prog Retin Eye Res       Date:  2017-06-08       Impact factor: 21.198

Review 4.  New insights into the role of connexins in pancreatic islet function and diabetes.

Authors:  Nikki L Farnsworth; Richard K P Benninger
Journal:  FEBS Lett       Date:  2014-02-28       Impact factor: 4.124

5.  Connexin30.2: In Vitro Interaction with Connexin36 in HeLa Cells and Expression in AII Amacrine Cells and Intrinsically Photosensitive Ganglion Cells in the Mouse Retina.

Authors:  Arndt Meyer; Stephan Tetenborg; Helena Greb; Jasmin Segelken; Birthe Dorgau; Reto Weiler; Sheriar G Hormuzdi; Ulrike Janssen-Bienhold; Karin Dedek
Journal:  Front Mol Neurosci       Date:  2016-05-27       Impact factor: 5.639

Review 6.  Connexins and Glucose Metabolism in Cancer.

Authors:  Jennifer C Jones; Thomas M Bodenstine
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.